Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Biogen Medicare CNN headline
View:
Post by Gbathat on Nov 13, 2021 1:25pm

Biogen Medicare CNN headline

Currently the headline story on CNN

The federal government announced a large hike in Medicare premiums Friday night, blaming the pandemic but also what it called uncertainty over how much it may have to be forced to pay for a pricey and controversial new Alzheimer's drug.


Looks like Biogen is setting PMN up to save the day... technically and financially
Comment by M101 on Nov 13, 2021 7:17pm
Yup, If there was no AD drug in time to fix Biden then nobody should get one. Besides if we can't contain China we might as well forget everything. Vote Manchin not Manchurian! 
Comment by JackRedwood on Nov 15, 2021 3:40pm
M101, I'm confused as to what you are saying, to me it sounds sort of racist. 
Comment by M101 on Nov 15, 2021 6:11pm
It was a bit cryptic. The Biden administration has pumped up up the propaganda war against China even from Trump, who pumped it up from Obama. We're supposed to be afraid of China again so that the MIC doesn't have any slow quarters following the afghan pull out, and as a distraction from the accelerating collapse of empire under it's own neoliberal weight.  Then there's ...more  
ProMIS Neurosciences Inc